{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:25Z","timestamp":1786114945209,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2021 ID 25788"],"award-info":[{"award-number":["IG 2021 ID 25788"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.molpha.2026.100137","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:33:35Z","timestamp":1781739215000},"page":"100137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective in vitro effects of histone deacetylase 6\u2013selective inhibitor SW-100 toward oxaliplatin-derived toxicity"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-5603","authenticated-orcid":false,"given":"Angelica","family":"Squarzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Scuteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9495-4256","authenticated-orcid":false,"given":"Elisabetta","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-1576","authenticated-orcid":false,"given":"Virginia","family":"Rodriguez-Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-2406","authenticated-orcid":false,"given":"Guido","family":"Cavaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2026.100137_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation","volume":"11","author":"Shukla","year":"2020","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.molpha.2026.100137_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol Cancer Res"},{"issue":"suppl 1","key":"10.1016\/j.molpha.2026.100137_bib3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6603463","article-title":"Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor","volume":"95","author":"Richon","year":"2006","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.molpha.2026.100137_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/0973-1482.137937","article-title":"Epigenetic therapy of cancer with histone deacetylase inhibitors","volume":"10","author":"Lakshmaiah","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.molpha.2026.100137_bib5","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.molpha.2026.100137_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105274","article-title":"HDAC6 as privileged target in drug discovery: a perspective","volume":"163","author":"Pulya","year":"2021","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.molpha.2026.100137_bib7","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3390\/ijms23062996","article-title":"Emerging role of HDACs in regeneration and ageing in the peripheral nervous system: repair Schwann cells as pivotal targets","volume":"23","author":"Gomez-Sanchez","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?","volume":"8","author":"Sim\u00f5es-Pires","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.molpha.2026.100137_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123219","article-title":"Curriculum vitae of HDAC6 in solid tumors","volume":"230","author":"Zheng","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in Diseases of cognition and of neurons","volume":"10","author":"LoPresti","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.molpha.2026.100137_bib11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acschemneuro.8b00600","article-title":"Brain penetrable histone deacetylase 6 inhibitor SW-100 ameliorates memory and learning impairments in a mouse model of fragile X syndrome","volume":"10","author":"Kozikowski","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"14","key":"10.1016\/j.molpha.2026.100137_bib12","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.3390\/cancers13143575","article-title":"HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity","volume":"13","author":"Karagiannis","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.molpha.2026.100137_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000210400","article-title":"Expression of p-Akt in sensory neurons and spinal cord after peripheral nerve injury","volume":"17","author":"Shi","year":"2009","journal-title":"Neurosignals"},{"issue":"5","key":"10.1016\/j.molpha.2026.100137_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.molpha.2026.100137_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jns5.12073","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know","volume":"19","author":"Cavaletti","year":"2014","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"10.1016\/j.molpha.2026.100137_bib16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.bjc.6602215","article-title":"Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells","volume":"91","author":"Arango","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.molpha.2026.100137_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1040-8428(00)00070-6","article-title":"Oxaliplatin clinical activity: a review","volume":"35","author":"Misset","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.molpha.2026.100137_bib19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zaj\u0105czkowska","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"S2","key":"10.1016\/j.molpha.2026.100137_bib20","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/jns.12335","article-title":"Platinum-induced peripheral neurotoxicity: from pathogenesis to treatment","volume":"24","author":"Staff","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.molpha.2026.100137_bib21","series-title":"The Impact of Food Bioactives on Health","first-page":"113","article-title":"HT29 cell line","author":"Mart\u00ednez-Maqueda","year":"2015"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jcp.1041490105","article-title":"Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro","volume":"149","author":"Jumarie","year":"1991","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100137_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-4608(94)00225-Z","article-title":"DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin","volume":"81","author":"Chen","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib24","first-page":"219","article-title":"Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line","volume":"24","author":"Marchetti","year":"2004","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2006.07.127","article-title":"Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying","volume":"1116","author":"Scuteri","year":"2006","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.molpha.2026.100137_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100049","article-title":"Analyzing lognormal data: a nonmathematical practical guide","volume":"77","author":"Motulsky","year":"2025","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100137_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1083\/jcb.103.2.571","article-title":"The acetylation of alpha-tubulin and its relationship to the assembly and disassembly of microtubules","volume":"103","author":"Maruta","year":"1986","journal-title":"J Cell Biol"},{"issue":"22","key":"10.1016\/j.molpha.2026.100137_bib29","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1007\/s00018-015-2000-5","article-title":"Tubulin acetylation: responsible enzymes, biological functions and human diseases","volume":"72","author":"Li","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.molpha.2026.100137_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn.2017.46","article-title":"The emerging field of epigenetics in neurodegeneration and neuroprotection","volume":"18","author":"Hwang","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.molpha.2026.100137_bib31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/cancers12061370","article-title":"Management of oxaliplatin-induced peripheral sensory neuropathy","volume":"12","author":"Cavaletti","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molpha.2026.100137_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1345811","article-title":"Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy","volume":"17","author":"Chen","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.molpha.2026.100137_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbi.2021.12.005","article-title":"An HDAC6 inhibitor reverses chemotherapy-induced mechanical hypersensitivity via an IL-10 and macrophage dependent pathway","volume":"100","author":"Zhang","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.1016\/j.molpha.2026.100137_bib34","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1097\/j.pain.0000000000001667","article-title":"Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers","volume":"160","author":"Ma","year":"2019","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.molpha.2026.100137_bib35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/toxics13090767","article-title":"ITF6475, a new histone deacetylase 6 inhibitor, prevents painful neuropathy induced by paclitaxel","volume":"13","author":"Cavaletti","year":"2025","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.molpha.2026.100137_bib37","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/gut.2004.052704","article-title":"Apoptosis and colorectal cancer","volume":"53","author":"Watson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.molpha.2026.100137_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113141","article-title":"Pathogenesis of platinum-induced peripheral neurotoxicity: insights from preclinical studies","volume":"325","author":"Calls","year":"2020","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1016\/j.molpha.2026.100137_bib39","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1111\/j.1460-9568.2004.03750.x","article-title":"Caspase signalling in neuropathic and inflammatory pain in the rat","volume":"20","author":"Joseph","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1523\/JNEUROSCI.09-01-00358.1989","article-title":"Dynamics of \u03b1-tubulin deacetylation in intact neurons","volume":"9","author":"Black","year":"1989","journal-title":"J Neurosci"},{"key":"10.1016\/j.molpha.2026.100137_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.684714","article-title":"HDAC6: A key link between mitochondria and development of peripheral neuropathy","volume":"14","author":"English","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100137_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65094-1","article-title":"A novel insight into neurological disorders through HDAC6 protein\u2013protein interactions","volume":"14","author":"Bahram Sangani","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.molpha.2026.100137_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010848","article-title":"HDAC6 regulates mitochondrial transport in hippocampal neurons","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.molpha.2026.100137_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/acschemneuro.9b00338","article-title":"Novel HDAC6 inhibitors increase tubulin acetylation and rescue axonal transport of mitochondria in a model of Charcot\u2013Marie\u2013Tooth type 2F","volume":"11","author":"Adalbert","year":"2020","journal-title":"ACS Chem Neurosci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:11:05Z","timestamp":1785971465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0026895X26000374"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100137","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective in vitro effects of histone deacetylase 6\u2013selective inhibitor SW-100 toward oxaliplatin-derived toxicity","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100137"}}